Interleukin-33 (IL-33) is overexpressed in the CNS of MS patients both in cortical lesions (plaques) and in healthy regions of the brain and spinal cord, compared with healthy volunteers (91). This evidence concerns the gene IL33 and myeloid sarcoma.